#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovitis Henoch-Schonlein purpura Small cell lung cancer extensive stage Cytomegalovirus infection Optic glioma Anti-myelin-associated glycoprotein antibodies positive Hereditary neuropathic amyloidosis Interstitial lung disease Hypereosinophilic syndrome Warm autoimmune haemolytic anaemia Pleural mesothelioma malignant Follicle centre lymphoma follicular grade I, II – III Leiomyosarcoma recurrent Peripheral T-cell lymphoma unspecified Demyelination More trials…

    Learn about Rare Diseases

    Prader-Willi syndrome – Life with Disease Amyotrophic lateral sclerosis Primary hyperoxaluria – Treatment Haemophagocytic lymphohistiocytosis – Life with Disease Loeys-Dietz syndrome Hereditary optic atrophy – Diagnostics Nodal marginal zone B-cell lymphoma – Treatment Andersen-Tawil syndrome – Diagnostics Hepatoblastoma – Life with Disease Langerhans cell sarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Carfilzomib Sodium S-Lactate Solution Gsk4381562A Ciclosporin Adezunap Defactinib Gsk3858279 Fexofenadine UDONITRECTAG Bi 764532 Timrepigene Emparvovec FG001 Pc14586 Carboplatin ZOREVUNERSEN SODIUM Ipatasertib Radiprodil Oteracil Tertomotide Zipalertinib More therapies…

    Learn about Your Condition

    Developmental hip dysplasia Endometrial cancer stage II Cardiac failure Hepatic cirrhosis Milk allergy Perinatal depression Pleural mesothelioma malignant Procedural haemorrhage Major depression Adenosquamous cell lung cancer Glomerulonephritis chronic Hyperlipidaemia Myotonic dystrophy Caesarean section Retinal neovascularisation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A Study of ACP-204 Tartrate for Adults With Lewy Body Dementia Psychosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy

  • Study of Semaglutide on Embryo Quality in Overweight and Obese Women Undergoing In Vitro Fertilization for Infertility

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility
    Investigated Drugs:
    • Follitropin Alfa
    • Ganirelix
    • Triptorelin
    Spain

  • A study testing sirolimus to slow disease progression in patients with familial adenomatous polyposis

    Recruiting

    3 1
    Investigated Diseases:
    • Adenomatous polyposis coli
    Investigated Drugs:
    • Sirolimus
    Denmark Germany Italy The Netherlands Spain

  • Testing Bisoprolol in Patients with Acute or Recurrent Pericarditis to Reduce Symptoms and Prevent Recurrence

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hypotension
    Investigated Drugs:
    • Bisoprolol
    Italy

  • Study of ipilimumab and nivolumab injected into tumors before surgery in patients with stage III melanoma that can be removed by surgery

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Study Using PET Imaging to See How [89Zr]Zr-DFO-CIT-013 Spreads in Patients with Inflammatory Mediated Immune Diseases

    Recruiting

    2 1 1
    Investigated Diseases:
    • Autoimmune disorder
    Investigated Drugs:
    • [89ZR]ZR-DFO-CIT-013
    The Netherlands
Previous Page
1 … 111 112 113 114 115 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!